Epigenetic regulation in lean nonalcoholic fatty liver disease
I Aggeletopoulou, M Kalafateli, EP Tsounis… - International Journal of …, 2023 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD), the most prominent cause of chronic liver disease
worldwide, is a rapidly growing epidemic. It consists of a wide range of liver diseases, from …
worldwide, is a rapidly growing epidemic. It consists of a wide range of liver diseases, from …
[HTML][HTML] Genetic and metabolic characteristics of lean nonalcoholic fatty liver disease in a Korean health examinee cohort
H Park, EL Yoon, GE Chung, EK Choe, JH Bae… - Gut and liver, 2024 - ncbi.nlm.nih.gov
Methods This retrospective cross-sectional study analyzed single nucleotide polymorphism
data for 6,939 health examinees. Lean individuals were categorized according to a body …
data for 6,939 health examinees. Lean individuals were categorized according to a body …
Dietary inflammatory impact on NAFLD development in obese vs. lean individuals: an analysis based on NHANES 2003–2018
L Li, X Shu, Y Yi, C Wang, J Li, Y Ding, J Li… - Lipids in Health and …, 2024 - Springer
Background Non-alcoholic fatty liver disease (NAFLD), often linked with obesity, can also
affect individuals with normal weight, a condition known as “lean NAFLD”, imposing …
affect individuals with normal weight, a condition known as “lean NAFLD”, imposing …
非肥胖人群胆结石检出率与危险因素分析
师阿盟， 何鑫， 王莹， 姜珏， 周琦， 王倩… - 实用肝脏病 …, 2024 - manu43.magtech.com.cn
目的调查非肥胖体检人群胆结石检出率及其危险因素. 方法2021 年1 月~ 2021 年12
月西安交通大学第二附属医院健康管理中心参加体检的非肥胖人群(BMI≤ 24 kg/m 2) …
月西安交通大学第二附属医院健康管理中心参加体检的非肥胖人群(BMI≤ 24 kg/m 2) …
Characterization of Cyclo His-Pro for the prevention and treatment of liver disease and muscular dystrophy
A De Masi - 2023 - infoscience.epfl.ch
Abstract The natural compound Cyclo Histidine-Proline (CHP) was initially discovered in the
brain, but thereafter evaluated in the context of diabetes because of its hypoglycemic action …
brain, but thereafter evaluated in the context of diabetes because of its hypoglycemic action …